MBLAC1 and Alzheimer disease: Our findings of altered glucose and cholesterol homeostasis, along with changes in heart mass, suggest the presence of a metabolic syndrome that may drive the cardiovascular dysfunction associated with AD who demonstrate reduced MBLAC1 expression.